BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of subcutaneously administrated insulin and its clinical implications. 1985

T Lauritzen

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003930 Diabetic Retinopathy Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Lauritzen
Pharmacokinetics of subcutaneously injected tritiated insulin: effects of exercise.
January 1979, Diabetes,
T Lauritzen
Pharmacokinetics of insulin and glucagon injected subcutaneously in the elderly.
March 1984, Medical journal of Osaka University,
T Lauritzen
Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications.
April 1976, British journal of clinical pharmacology,
T Lauritzen
Toxicity Study of Streptococcus pneumoniae Vaccine Administrated Subcutaneously in Rats.
June 2011, Toxicological research,
T Lauritzen
[Pharmacokinetics of insulin administered subcutaneously. Application to treatment by portable pump (1)].
January 1989, Diabete & metabolisme,
T Lauritzen
Pharmacokinetics and pharmacodynamics of subcutaneously administered U40 and U100 formulations of regular human insulin.
January 1992, Diabete & metabolisme,
T Lauritzen
[Role of P-glycoprotein in pharmacokinetics and its clinical implications].
August 2005, Yao xue xue bao = Acta pharmaceutica Sinica,
T Lauritzen
Comparative pharmacokinetics and insulin action for three rapid-acting insulin analogs injected subcutaneously with and without hyaluronidase.
February 2013, Diabetes care,
T Lauritzen
Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man.
December 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
T Lauritzen
Pharmacokinetics and pharmacodynamics of subcutaneously administered PYY3-36 and its analogues in vivo.
February 2015, Lancet (London, England),
Copied contents to your clipboard!